INTRATYMPANIC INJECTION OF SUSTAINED-EXPOSURE DEXAMETHASONE THERMOSENSITIVE GEL (OTO-104) FOR PREVENTION OF CISPLATIN-INDUCED HEARING LOSS IN CHILDREN IS FEASIBLE AND SAFE

PEDIATRIC BLOOD & CANCER(2022)

引用 0|浏览25
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要